专题：Breast Cancer Treatment Studies

This cluster of papers focuses on molecular research, treatment response, and prognostic markers in breast cancer. It covers topics such as gene expression patterns, molecular subtypes, neoadjuvant therapy, radiotherapy, and the impact of hormone receptors on survival. The papers also discuss the development of clinical practice guidelines for breast cancer management.
最新文献
Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 years and older with high-risk breast cancer based on the genomic grade index (ASTER 70s): a randomised phase 3 trial

article Full Text OpenAlex

Association of Surgeon Volume with Adherence to American Society of Breast Surgeons Surgical Quality Measures

article Full Text OpenAlex

Complication Rates are Low After Invasive Procedures on the Lactating Breast in Patients Treated for Breast Cancer During Pregnancy

article Full Text OpenAlex

Contrast-Enhanced Mammography-Guided Biopsy: A Step-by-Step Guide

article Full Text OpenAlex

Hormone therapy use and young-onset breast cancer: a pooled analysis of prospective cohorts included in the Premenopausal Breast Cancer Collaborative Group

article Full Text OpenAlex

Postoperative Outcomes After Breast Reduction: Do Racial Disparities Exist?

article Full Text OpenAlex

The current practice of volumetric modulated arc therapy for breast cancer in Europe – A survey by the EFOMP VMAT breast working group

article Full Text OpenAlex

Indocyanine Green Fluorescence-Guided Axillary Reverse Mapping for Axillary Lymph Node Dissection in Breast Cancer: The FARM Trial

article Full Text OpenAlex

Bilateral Primary Breast Cancer: A Case of Synchronous Diagnosis and Management of Ductal Carcinoma In Situ and Invasive Ductal Carcinoma

article Full Text OpenAlex

In Regard to Leonardi et al, “Salvage breast conserving surgery and reirradiation with intraoperative electrons for recurrent breast cancer: A multicentric study on behalf of AIRO (Italian Association of Radiotherapy and clinical Oncology)”

letter Full Text OpenAlex

近5年高被引文献
Breast Cancer Statistics, 2022

article Full Text OpenAlex 1964 FWCI263.563

Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer

article Full Text OpenAlex 1398 FWCI129.346

Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review

review Full Text OpenAlex 1306 FWCI33.32

Breast cancer

review Full Text OpenAlex 1241 FWCI48.624

ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer

article Full Text OpenAlex 987 FWCI128.187

Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

article Full Text OpenAlex 822 FWCI97.992

Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline

article Full Text OpenAlex 754 FWCI60.462

Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer

article Full Text OpenAlex 737 FWCI92.034

Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021

review Full Text OpenAlex 656 FWCI19.127

Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer

article Full Text OpenAlex 555 FWCI104.672